Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Theodorescu

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Oncogene|August 30, 2008
Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migrationY Wu, M S Siadaty, M E Berens, et al.
Anticancer Research|July 1, 1993
Lack of influence of c-Ha-ras expression on the drug sensitivity of human bladder cancer histocultured in three-dimensionsD Theodorescu, K M Connors, A Groce, et al.
Oncogene|December 26, 2001
Cell density mediated pericellular hypoxia leads to induction of HIF-1alpha via nitric oxide and Ras/MAP kinase mediated signaling pathwaysE A Sheta, H Trout, J J Gildea, et al.
The Journal of Urology|September 8, 2001
Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black menE A Bissonette, B R Fulmer, G R Petroni, et al.
Clinical & Experimental Metastasis|October 11, 2001
The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell linesM J Seraj, M A Harding, J J Gildea, et al.
Oncogene|August 1, 2006
Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexiaY Wu, K McRoberts, S S Berr, et al.
Cancer|December 10, 1997
Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostateD Theodorescu, S R Broder, J C Boyd, et al.
The Journal of Urology|July 1, 1997
p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostateD Theodorescu, S R Broder, J C Boyd, et al.
Genomics|October 13, 2001
An 800-kb region of deletion at 13q14 in human prostate and other carcinomasC Chen, H F Frierson, P F Haggerty, et al.
The Journal of Urology|April 29, 1998
Urethral replacement with vascularized tunica vaginalis: defining the optimal form of useD Theodorescu, A Balcom, C R Smith, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Oncogene|August 30, 2008
Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migrationY Wu, M S Siadaty, M E Berens, et al.
Anticancer Research|July 1, 1993
Lack of influence of c-Ha-ras expression on the drug sensitivity of human bladder cancer histocultured in three-dimensionsD Theodorescu, K M Connors, A Groce, et al.
Oncogene|December 26, 2001
Cell density mediated pericellular hypoxia leads to induction of HIF-1alpha via nitric oxide and Ras/MAP kinase mediated signaling pathwaysE A Sheta, H Trout, J J Gildea, et al.
The Journal of Urology|September 8, 2001
Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black menE A Bissonette, B R Fulmer, G R Petroni, et al.
Clinical & Experimental Metastasis|October 11, 2001
The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell linesM J Seraj, M A Harding, J J Gildea, et al.
Oncogene|August 1, 2006
Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexiaY Wu, K McRoberts, S S Berr, et al.
Cancer|December 10, 1997
Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostateD Theodorescu, S R Broder, J C Boyd, et al.
The Journal of Urology|July 1, 1997
p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostateD Theodorescu, S R Broder, J C Boyd, et al.
Genomics|October 13, 2001
An 800-kb region of deletion at 13q14 in human prostate and other carcinomasC Chen, H F Frierson, P F Haggerty, et al.
The Journal of Urology|April 29, 1998
Urethral replacement with vascularized tunica vaginalis: defining the optimal form of useD Theodorescu, A Balcom, C R Smith, et al.
Pageof 8